Login / Signup

Pharmacoutilization and adherence to sacubitril/valsartan in real world: the REAL.IT study in HFrEF.

Massimo IacovielloGabriele Di GesaroFilippo Maria SarulloDaniela MianiMauro DriussiMichele CorrealeClaudio BilatoAndrea PassantinoErberto CarluccioAlessandra VillaniLuca Degli EspostiChiara d'AgostinoElena PeruzziSimone PoliAndrea di Lenarda
Published in: ESC heart failure (2023)
Real-world data on the use of sacubitril/valsartan in clinical practice in Italy show a rapid titration to the target dose, high therapeutic adherence enabling a good level of therapeutic management in line with ESC guidelines for patients with reduced ejection fraction.
Keyphrases
  • clinical practice
  • ejection fraction
  • electronic health record
  • type diabetes
  • glycemic control
  • big data
  • metabolic syndrome
  • adipose tissue
  • machine learning
  • data analysis
  • weight loss
  • quantum dots